Department of Exercise Physiology, School of Health Sciences, University of New South Wales, Sydney, NSW, Australia.
Centre for Pain IMPACT, Neuroscience Research Australia, Sydney, NSW, Australia.
Sports Med. 2021 Dec;51(12):2527-2546. doi: 10.1007/s40279-021-01542-6. Epub 2021 Sep 9.
Changes in body composition during cancer treatments have been linked with poorer outcomes, and increased morbidity and mortality. The effect of resistance training (RT) on body composition in cancer cohorts is debated.
We conducted a systematic review and meta-analysis to determine the effect of RT on body composition during and after treatment.
We searched five electronic databases for articles up to 1 February 2021 and included randomized controlled trials that compared RT with a non-exercise control in adults with cancer. Risk of bias was assessed using the RoB 2 tool. Pairwise, random-effects meta-analysis was used to synthesize the available data.
Overall, we included 15 studies (n = 1368). After treatment (11 studies), RT increased lean mass with moderate heterogeneity {0.41 kg [95% confidence interval (CI) 0.05, 0.76], p = 0.029; I = 47.1%, p = 0.02} and decreased fat mass with substantial heterogeneity (- 0.59 kg [95% CI - 1.05, - 0.12], p = 0.019; I = 69.1%, p < 0.001). During treatment (4 studies), RT did not increase lean mass (0.71 kg [95% CI - 0.04, 1.45], p = 0.05; I = 0.0%, p = 0.75) or reduce fat mass (0.00 kg [95% CI - 5.31, 5.30], p = 0.99; I = 0.0%, p = 0.62), both with no heterogeneity.
Modest improvements in body composition were observed following RT after cancer treatment; however, no changes were observed during treatment. These adaptations are markedly lower than those observed in healthy cohorts but may be clinically meaningful for the cancer survivorship population. At present it is unclear if these diminished adaptations are due to ineffective exercise prescriptions in cancer cohorts or due to an innate anabolic resistance as a result of cancer and its treatments.
Open Science Framework (osf.io/x6z72).
癌症治疗过程中身体成分的变化与较差的治疗效果有关,并且会增加发病率和死亡率。关于阻力训练(RT)对癌症患者身体成分的影响存在争议。
我们进行了一项系统评价和荟萃分析,以确定 RT 在治疗期间和治疗后对身体成分的影响。
我们在截至 2021 年 2 月 1 日的五个电子数据库中搜索了比较癌症成人接受 RT 与非运动对照组的随机对照试验。使用 RoB 2 工具评估偏倚风险。使用成对、随机效应荟萃分析来综合可用数据。
总体而言,我们纳入了 15 项研究(n=1368)。治疗后(11 项研究),RT 适度增加了瘦体重[0.41kg(95%置信区间 0.05,0.76),p=0.029;I=47.1%,p=0.02],并大量减少了脂肪量[-0.59kg(95%置信区间-1.05,-0.12),p=0.019;I=69.1%,p<0.001]。治疗期间(4 项研究),RT 没有增加瘦体重(0.71kg(95%置信区间-0.04,1.45),p=0.05;I=0.0%,p=0.75)或减少脂肪量(0.00kg(95%置信区间-5.31,5.30),p=0.99;I=0.0%,p=0.62),两者均无差异。
癌症治疗后进行 RT 可适度改善身体成分;然而,在治疗期间没有观察到变化。这些适应性改变明显低于健康队列观察到的适应性改变,但对于癌症生存者人群可能具有临床意义。目前尚不清楚这些适应性改变是由于癌症患者的运动处方无效,还是由于癌症及其治疗导致的固有合成代谢抵抗。
开放科学框架(osf.io/x6z72)。